NGS enters its two-brand phase with lower cash burn and Sprout now in the group

Cash burn falls as NGS completes its two-brand transition

Nutritional Growth Solutions Ltd (ASX:NGS) has reached the point where its acquisition story becomes an operating test. Net cash used in operations fell to US$90,000 in the September quarter, down 54% from US$195,000 in the June quarter and from US$426,000 in the first quarter of FY26. Shortly after quarter end, on 1 October, the company completed its acquisition of Sprout Organic and its logistics subsidiary Better Brands 3PL.

The result leaves NGS with US$1.613 million in cash at 30 September, equivalent to approximately A$2.3 million, and no borrowings or financing facilities. The cash balance was boosted by the A$2.5 million placement, which delivered US$1.741 million during the quarter after 125 million shares were issued at A$0.02 each. That funding came after the company’s A$2.5m Sprout placement had been announced as part of the acquisition funding plan.

Sprout deal nearly doubles the issued share count

The transaction materially changes the capital structure. NGS issued 401,228,887 consideration shares to Sprout shareholders, 45,771,114 shares to settle Sprout creditor loans and further shares on conversion of two tranches of convertible notes. The total issued share count rose from 487,313,207 at 30 September to 964,041,335 after completion, with 331,770,756 consideration shares voluntarily escrowed until 30 September 2027.

The acquisition also brought a leadership reset. Sprout founder Selasi Berdie became chief executive and executive director, while former interim chief executive and chief financial officer Manik Pujara moved to a non-executive director role. Joel Dening became chief operating officer. Berdie was installed as CEO as part of the Sprout acquisition transition, which earlier coverage said would reshape NGS around infant, toddler and children’s nutrition.

Operating improvement still needs to survive integration

The quarter’s cash figures are encouraging but not yet a clean measure of the combined business. US Healthy Heights operations generated a net operating cash inflow of US$122,000 before group corporate and executive costs, according to unaudited management accounts. Group administration and corporate costs increased to US$181,000, partly due to AGM, listing, compliance, audit, legal and integration work, while customer receipts fell to US$286,000 from US$338,000 because of invoicing and payment timing.

NGS advanced a further US$217,000 to Sprout before completion, taking total advances to US$442,000. The unsecured, interest-free loan became an intra-group balance on completion and will be eliminated on consolidation. Sprout’s cash flows are not included in this quarter’s Appendix 4C, meaning the December quarter will provide the first reported view of the enlarged group.

Cross-selling plans put execution ahead of the next cash report

Management has identified approximately A$870,000 in annualised savings from shared corporate functions, lower listing and director costs, back-office consolidation and procurement. Its operating plan is similarly expansive: Healthy Heights is intended to move into Australian manufacturing and Sprout’s Australian, Chinese and South-East Asian channels, while Sprout is planned for NGS’s US e-commerce channels. US infant-formula sales remain subject to FDA requirements.

The Appendix 4C calculates 17.92 quarters of funding based on the quarter-end cash balance and the US$90,000 operating outflow. That figure is a mechanical estimate rather than a forecast for the combined group: it excludes Sprout’s September cash flows, future integration spending, inventory requirements and the effect of the post-quarter cash payments, including A$650,000 to settle Sprout director loans and a A$250,000 advisory fee. The December quarter will therefore matter less for the headline cash balance than for whether the enlarged group can convert inventory, cross-selling and claimed savings into operating cash.